Skip to main content

Table 2 Comorbidities in COPD patients of rural/semi-urban areas of Greece

From: Adherence to inhalers and comorbidities in COPD patients. A cross-sectional primary care study from Greece

N (%)

Total Group

N = 257

Good-Intermediate adherence

N = 59

(25.9%)

Poor adherence

N = 169 (74.1%)

P-value*

≥2 comorbidities

189 (77.1)

43 (79.6)

129 (77.7)

0.915

Overweight-obese (≥ 25 Kg/m2)

203 (82.2)

43 (78.2)

142 (85.5)

0.284

Type II Diabetes Mellitus

28 (11.0)

9 (15.5)

17 (10.1)

0.375

Hypertension

186 (72.9)

39 (67.2)

127 (75.1)

0.317

Dyslipidaemia

63 (24.6)

17 (28.8)

41 (24.3)

0.605

Heart Disease

32 (12.5)

14 (23.7)

17 (10.1)

0.016

Thyroid disorder

19 (7.4)

7 (11.9)

11 (6.5)

0.259

Osteoporosis

7 (2.7)

6 (6.8)

2 (1.2)

0.040

Depression

23 (9)

6 (10.2)

16 (9.5)

0.999

Gastro-oesophageal reflux

30 (11.7)

20 (33.9)

9 (5.3)

< 0.001

Cancer (any)

3 (1.2)

2 (3.4)

1 (0.6)

0.165

  1. *Chi-square or Fisher’s exact test